VIA

Virtus Investment Advisers Portfolio holdings

AUM $368M
1-Year Est. Return 26.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$368M
AUM Growth
+$18.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
553
New
Increased
Reduced
Closed

Top Buys

1
+$2.17M
2
+$2.09M
3
+$2.03M
4
AMAT icon
Applied Materials
AMAT
+$2.01M
5
LVS icon
Las Vegas Sands
LVS
+$2.01M

Top Sells

1
+$2.5M
2
+$2.43M
3
+$2.05M
4
MS icon
Morgan Stanley
MS
+$2.04M
5
ATO icon
Atmos Energy
ATO
+$2.02M

Sector Composition

1 Healthcare 26.73%
2 Financials 22.73%
3 Technology 18.16%
4 Industrials 8.89%
5 Consumer Discretionary 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TYRA icon
251
Tyra Biosciences
TYRA
$1.75B
$309K 0.08%
11,756
+741
PHVS icon
252
Pharvaris
PHVS
$1.83B
$306K 0.08%
11,011
+4,407
EYPT icon
253
EyePoint Inc
EYPT
$1.51B
$304K 0.08%
16,638
+3,795
PGEN icon
254
Precigen
PGEN
$1.29B
$301K 0.08%
+72,095
BLTE
255
Belite Bio
BLTE
$6.65B
$301K 0.08%
1,882
+51
CAPR icon
256
Capricor Therapeutics
CAPR
$1.46B
$295K 0.08%
10,224
+2,061
RCUS icon
257
Arcus Biosciences
RCUS
$3.01B
$294K 0.08%
12,356
+187
VTYX icon
258
Ventyx Biosciences
VTYX
$1B
$293K 0.08%
+32,483
IMNM icon
259
Immunome
IMNM
$2.45B
$292K 0.08%
13,593
+1,970
SEPN
260
Septerna Inc
SEPN
$1.28B
$292K 0.08%
+10,457
PRAX icon
261
Praxis Precision Medicines
PRAX
$9.07B
$291K 0.08%
989
-1,538
XERS icon
262
Xeris Biopharma Holdings
XERS
$1B
$291K 0.08%
37,102
+11,358
ANAB icon
263
AnaptysBio
ANAB
$1.54B
$287K 0.08%
5,919
+1,059
ENGN icon
264
enGene Holdings
ENGN
$671M
$284K 0.08%
+31,445
DFTX
265
Definium Therapeutics
DFTX
$1.71B
$284K 0.08%
21,198
+5,611
MAZE
266
Maze Therapeutics
MAZE
$2.18B
$284K 0.08%
6,846
-1,551
IVVD icon
267
Invivyd
IVVD
$488M
$283K 0.08%
+114,668
PVLA
268
Palvella Therapeutics
PVLA
$1.58B
$282K 0.08%
+2,698
MBX
269
MBX Biosciences
MBX
$1.46B
$281K 0.08%
8,910
-1,704
TECX
270
Tectonic Therapeutic
TECX
$434M
$281K 0.08%
13,462
+8,391
RLAY icon
271
Relay Therapeutics
RLAY
$1.73B
$280K 0.08%
33,130
+148
EWTX icon
272
Edgewise Therapeutics
EWTX
$3.12B
$279K 0.08%
11,263
+3,883
RIGL icon
273
Rigel Pharmaceuticals
RIGL
$625M
$279K 0.08%
+6,524
IMTX icon
274
Immatics
IMTX
$1.34B
$278K 0.08%
26,497
+7,965
CMPX icon
275
Compass Therapeutics
CMPX
$1.02B
$277K 0.08%
+51,556
9 10
11
12 13